Company Filing History:
Years Active: 2006-2013
Title: Stéphanie Deprets: Innovator in Medicinal Chemistry
Introduction
Stéphanie Deprets is a notable inventor based in Paris, France. He has made significant contributions to the field of medicinal chemistry, particularly through his innovative compounds and their therapeutic applications. With a total of 3 patents, his work has garnered attention in the pharmaceutical industry.
Latest Patents
One of his latest patents is focused on 1-pyrazolo[4,3-c]isoquinoline derivatives, which includes the preparation and therapeutic use of these compounds. The invention relates to a compound of formula (I), where R is a phenyl group that may be substituted by one or more halogen atoms. Additionally, R can be a hydrogen atom, a halogen atom, or a cyano group. The patent also describes various functional groups that can be attached to the core structure, showcasing the versatility of these compounds in medicinal applications. Another significant patent involves benzothiazoles and their use as medicaments, highlighting novel chemical compounds and their potential therapeutic benefits.
Career Highlights
Stéphanie has worked with prominent companies in the pharmaceutical sector, including Aventis Pharma S.A. and Sanofi-Aventis. His experience in these organizations has allowed him to develop and refine his innovative ideas, contributing to advancements in drug development.
Collaborations
Throughout his career, Stéphanie has collaborated with esteemed colleagues such as Odile Angouillant-Boniface and Anke Steinmetz. These partnerships have facilitated the exchange of ideas and fostered a collaborative environment for innovation.
Conclusion
Stéphanie Deprets stands out as a key figure in the field of medicinal chemistry, with a focus on developing novel compounds for therapeutic use. His contributions through patents and collaborations continue to impact the pharmaceutical industry positively.